The feasibility of conducting clinical trials in infants and children with acute respiratory failure (Q43917027)

28 November 2017

The feasibility of conducting clinical trials in infants and children with acute respiratory failure (English)

1 reference

28 November 2017

Rainer G Gedeit

7

0 references

Adrienne G Randolph

object named as

Adrienne G Randolph

1

0 references

Ira M. Cheifetz

object named as

Ira M Cheifetz

12

0 references

author name string

Kathleen L Meert

2

1 reference

28 November 2017

Mary E O'Neil

3

1 reference

28 November 2017

James H Hanson

4

1 reference

28 November 2017

Peter M Luckett

5

1 reference

28 November 2017

John H Arnold

6

1 reference

28 November 2017

Peter N Cox

8

1 reference

28 November 2017

Joan S Roberts

9

1 reference

28 November 2017

Shekhar T Venkataraman

10

1 reference

28 November 2017

Peter W Forbes

11

1 reference

28 November 2017

Pediatric Acute Lung Injury and Sepsis Investigators Network

13

1 reference

28 November 2017

language of work or name

English

0 references

publication date

25 February 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

28 November 2017

1 reference

28 November 2017

167

1 reference

28 November 2017

10

1 reference

28 November 2017

1334-1340

1 reference

Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure.

28 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Effect of mechanical ventilator weaning protocols on respiratory outcomes in infants and children: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

PRISM III: an updated Pediatric Risk of Mortality score

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Is there a place for exogenous surfactant in mechanically ventilated infants with severe respiratory syncytial virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Porcine-derived surfactant treatment of severe bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Vitamin A and respiratory syncytial virus infection. Serum levels and supplementation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Acute respiratory distress syndrome caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Members of the Mid-Atlantic Pediatric Critical Care Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Helium-oxygen improves Clinical Asthma Scores in children with acute bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Asthma and wheezing in the first six years of life. The Group Health Medical Associates

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

The effects of early and repeated prone positioning in pediatric patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

Tidal volumes for ventilated infants should be determined with a pneumotachometer placed at the endotracheal tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200210-1175OC

10.1164/RCCM.200210-1175OC

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference